Q3 2024 |
62 |
$5.97B |
+$158M |
-$398M |
-$240M |
MSFT, JPM, ABBV, ACN, PEP
|
13F-HR |
11/7/2024, 09:46 AM |
Q2 2024 |
63 |
$6.06B |
+$26.7M |
-$49.6M |
-$22.9M |
MSFT, JPM, AVGO, BLK, LRCX
|
13F-HR |
8/8/2024, 11:38 AM |
Q1 2024 |
62 |
$6.09B |
+$229M |
-$99.2M |
+$130M |
MSFT, JPM, BLK, AVGO, ABBV
|
13F-HR |
5/3/2024, 09:16 AM |
Q4 2023 |
61 |
$5.56B |
+$23.9M |
-$17.9M |
+$6.02M |
MSFT, JPM, BLK, AVGO, ACN
|
13F-HR |
2/8/2024, 09:43 AM |
Q3 2023 |
60 |
$5.05B |
+$18.3M |
-$8.98M |
+$9.31M |
MSFT, JPM, BLK, PEP, ABBV
|
13F-HR |
11/3/2023, 09:00 AM |
Q2 2023 |
60 |
$5.26B |
+$71.5M |
$0 |
+$71.5M |
MSFT, JPM, BLK, PEP, ACN
|
13F-HR |
8/8/2023, 09:31 AM |
Q1 2023 |
57 |
$4.99B |
+$11.9M |
$0 |
+$11.9M |
MSFT, JPM, BLK, PEP, ABBV
|
13F-HR |
5/5/2023, 10:34 AM |
Q4 2022 |
56 |
$5.01B |
+$56.8M |
-$41.7M |
+$15.1M |
MSFT, BLK, JPM, ABBV, PEP
|
13F-HR |
2/9/2023, 10:27 AM |
Q3 2022 |
57 |
$4.37B |
+$84.9M |
-$70.1M |
+$14.8M |
MSFT, BLK, JPM, PEP, ABBV
|
13F-HR |
11/8/2022, 09:24 AM |
Q2 2022 |
80 |
$4.72B |
+$46.7M |
-$39.2M |
+$7.57M |
MSFT, BLK, JPM, ABBV, PEP
|
13F-HR |
8/5/2022, 09:23 AM |
Q1 2022 |
78 |
$5.23B |
+$29M |
-$24.9M |
+$4.08M |
MSFT, BLK, JPM, ABBV, ACN
|
13F-HR |
5/12/2022, 09:52 AM |
Q4 2021 |
75 |
$5.54B |
+$1.39M |
-$6.34M |
-$4.95M |
MSFT, BLK, JPM, ACN, PEP
|
13F-HR |
2/11/2022, 09:59 AM |
Q3 2021 |
77 |
$4.91B |
+$6.42M |
-$5.53M |
+$893K |
MSFT, JPM, BLK, ACN, PEP
|
13F-HR |
11/5/2021, 10:05 AM |
Q2 2021 |
76 |
$4.95B |
+$15.5M |
-$19.1M |
-$3.62M |
MSFT, BLK, JPM, ACN, PEP
|
13F-HR |
8/6/2021, 11:15 AM |
Q1 2021 |
78 |
$4.72B |
+$28.2M |
-$24.4M |
+$3.84M |
JPM, MSFT, BLK, ACN, PEP
|
13F-HR |
5/6/2021, 09:36 AM |
Q4 2020 |
79 |
$4.42B |
+$23.8M |
-$12.1M |
+$11.6M |
MSFT, BLK, JPM, PEP, ACN
|
13F-HR |
2/12/2021, 09:27 AM |
Q3 2020 |
81 |
$3.93B |
+$117M |
-$80.6M |
+$36.1M |
MSFT, BLK, JPM, PEP, JNJ
|
13F-HR |
11/6/2020, 09:05 AM |
Q2 2020 |
80 |
$3.74B |
+$123M |
-$107M |
+$15.5M |
MSFT, BLK, JPM, PEP, JNJ
|
13F-HR |
8/6/2020, 09:34 AM |
Q1 2020 |
76 |
$3.22B |
+$63.1M |
-$15.6M |
+$47.5M |
MSFT, JPM, BLK, PEP, JNJ
|
13F-HR |
5/8/2020, 09:24 AM |
Q4 2019 |
75 |
$4.06B |
+$7.24M |
-$3.01M |
+$4.23M |
JPM, MSFT, BLK, PEP, JNJ
|
13F-HR |
2/11/2020, 10:13 AM |
Q3 2019 |
76 |
$3.8B |
+$49.8M |
-$28.2M |
+$21.6M |
JPM, MSFT, BLK, PEP, HAS
|
13F-HR |
11/5/2019, 10:20 AM |
Q2 2019 |
68 |
$3.74B |
+$17.5M |
-$23.9M |
-$6.39M |
JPM, MSFT, BLK, PEP, JNJ
|
13F-HR |
8/7/2019, 11:01 AM |
Q1 2019 |
68 |
$3.57B |
+$25.8M |
-$10.6M |
+$15.2M |
JPM, MSFT, BLK, PEP, JNJ
|
13F-HR |
5/3/2019, 09:37 AM |
Q4 2018 |
69 |
$3.22B |
+$122M |
-$84.9M |
+$37.1M |
JPM, BLK, MSFT, PFE, PEP
|
13F-HR |
2/11/2019, 11:51 AM |
Q3 2018 |
69 |
$3.57B |
+$78.5M |
-$76.9M |
+$1.66M |
JPM, BLK, MSFT, PFE, JNJ
|
13F-HR |
11/6/2018, 10:03 AM |
Q2 2018 |
70 |
$3.35B |
+$61.4M |
-$49.6M |
+$11.9M |
JPM, BLK, MSFT, PEP, ABBV
|
13F-HR |
8/13/2018, 09:51 AM |
Q1 2018 |
68 |
$3.32B |
+$31.2M |
-$72M |
-$40.8M |
JPM, BLK, PEP, MSFT, ABBV
|
13F-HR |
5/10/2018, 01:27 PM |
Q4 2017 |
69 |
$3.49B |
+$67.1M |
-$138M |
-$71.2M |
JPM, BLK, PEP, JNJ, ABBV
|
13F-HR |
2/13/2018, 09:14 AM |
Q3 2017 |
73 |
$3.35B |
+$41.2M |
-$1.68M |
+$39.5M |
JPM, BLK, PEP, JNJ, HAS
|
13F-HR |
11/3/2017, 10:36 AM |
Q2 2017 |
68 |
$3.22B |
+$25.2M |
-$39M |
-$13.8M |
JPM, BLK, PEP, HAS, JNJ
|
13F-HR |
8/8/2017, 09:32 AM |
Q1 2017 |
69 |
$3.16B |
+$133M |
-$171M |
-$37.3M |
JPM, BLK, PEP, JNJ, HAS
|
13F-HR |
5/8/2017, 10:10 AM |
Q4 2016 |
69 |
$3.08B |
+$8.51M |
-$115M |
-$107M |
JPM, BLK, PEP, XOM, JNJ
|
13F-HR |
2/15/2017, 09:59 AM |
Q3 2016 |
70 |
$3.07B |
+$13.6M |
-$49.7M |
-$36.1M |
BLK, PEP, JPM, JNJ, XOM
|
13F-HR |
11/7/2016, 11:20 AM |
Q2 2016 |
72 |
$3.05B |
+$142M |
-$68M |
+$73.6M |
PEP, BLK, JPM, JNJ, XOM
|
13F-HR |
8/9/2016, 10:12 AM |
Q1 2016 |
70 |
$2.85B |
+$85M |
-$96.1M |
-$11.2M |
BLK, PEP, JPM, JNJ, XOM
|
13F-HR |
5/6/2016, 10:06 AM |
Q4 2015 |
69 |
$2.74B |
+$73.4M |
-$74.9M |
-$1.56M |
JPM, BLK, PEP, PFE, JNJ
|
13F-HR |
2/9/2016, 09:55 AM |
Q3 2015 |
71 |
$2.62B |
+$95.3M |
$0 |
+$95.3M |
JPM, PEP, BLK, PFE, XOM
|
13F-HR |
11/10/2015, 09:45 AM |
Q2 2015 |
69 |
$2.73B |
+$159M |
-$157M |
+$2.21M |
JPM, BLK, PEP, PFE, XOM
|
13F-HR |
8/7/2015, 09:10 AM |
Q1 2015 |
71 |
$2.76B |
+$26.1M |
-$75.6M |
-$49.5M |
BLK, JPM, PEP, PFE, XOM
|
13F-HR |
5/8/2015, 09:38 AM |
Q4 2014 |
75 |
$2.86B |
+$34.6M |
-$66.1M |
-$31.6M |
BLK, JPM, XOM, PEP, JNJ
|
13F-HR |
2/10/2015, 09:49 AM |
Q3 2014 |
77 |
$2.79B |
+$123M |
-$88.1M |
+$34.6M |
BLK, XOM, JPM, PEP, JNJ
|
13F-HR |
11/7/2014, 10:24 AM |
Q2 2014 |
75 |
$2.78B |
+$13.8M |
-$16.4M |
-$2.63M |
XOM, BLK, JPM, PEP, JNJ
|
13F-HR |
8/8/2014, 09:33 AM |
Q1 2014 |
77 |
$2.71B |
+$6.19M |
-$1.96M |
+$4.23M |
XOM, JPM, BLK, PFE, PEP
|
13F-HR |
5/14/2014, 02:14 PM |
Q4 2013 |
76 |
$2.68B |
$0 |
$0 |
|
XOM, BLK, JPM, PEP, PFE
|
13F-HR |
2/11/2014, 10:53 AM |